Skip to main content

Advertisement

SpringerLink
Log in

Intracameral bevacizumab for rubeotic glaucoma secondary to retinal vein occlusion

  • Case report
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Two patients with ischaemic central retinal vein occlusion were treated with intracameral bevacizumab in order to affect the outcome of their disease. In addition, both patients underwent episodes of cycloablative and pan-retinal laser treatment. The patients were followed for more than 6 months and achieved some stability with a combination of these modalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Meyer CH, Mennel S, Eter N (2007) Incidence of endophthalmitis after intravitreal Avastin injection with and without postoperative topical antibiotic application. Ophthalmologe 104(11):952–957. doi:10.1007/s00347-007-1634-6

    Article  CAS  PubMed  Google Scholar 

  2. Fung AE, Rosenfeld PJ, Reichel E (2006) The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 90(11):1344–1349. doi:10.1136/bjo.2006.099598

    Article  CAS  PubMed  Google Scholar 

  3. Grisanti S, Biester S, Peters S, Tatar O, Ziemssen F, Bartz-Schmidt KU (2006) Intracameral bevacizumab for iris rubeosis: Tuebingen Bevacizumab Study Group. Am J Ophthalmol 142(1):158–160. doi:10.1016/j.ajo.2006.02.045

    Article  CAS  PubMed  Google Scholar 

  4. Raghuram A, Saravanan VR, Narendran V (2007) Intracameral injection of bevacizumab (Avastin) to treat anterior chamber neovascular membrane in a painful blind eye. Indian J Ophthalmol 55(6):460–462

    Article  CAS  PubMed  Google Scholar 

  5. Yazdani S, Hendi K, Pakravan M (2007) Intravitreal bevacizumab injection for neovascular glaucoma. J Glaucoma 16:437–439. doi:10.1097/IJG.0b013e3180457c47

    Article  PubMed  Google Scholar 

  6. Chalam KV, Gupta SK, Grover S, Brar VS, Agarwal S (2008) Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma. Eur J Ophthalmol 18(2):255–262

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bolton Hospitals NHS Trust, Bolton Eye Unit, Bolton NHS Trust, Minerva Road, Farnworth, Bolton, BL4 0JR, UK

    Kashif Qureshi & Simon P. Kelly

  2. Moorfields Eye Hospital NHS Trust, London, UK

    Shahram Kashani

Authors
  1. Kashif Qureshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shahram Kashani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Simon P. Kelly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kashif Qureshi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Qureshi, K., Kashani, S. & Kelly, S.P. Intracameral bevacizumab for rubeotic glaucoma secondary to retinal vein occlusion. Int Ophthalmol 29, 537–539 (2009). https://doi.org/10.1007/s10792-008-9262-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-008-9262-y

Keywords

Search

Navigation